Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Alnylam Pharmaceuticals Inc.
Headquarters:
Cambridge, MA, United States of America
Website:
http://www.alnylam.com
Year Founded:
2002
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Yvonne L. Greenstreet, MD, MBA
Number Of Employees:
2,230
Enterprise Value:
$30,086,471,810
PE Ratio:
-124.76
Exchange/Ticker 1:
NASDAQ:ALNY
Exchange/Ticker 2:
N/A
Latest Market Cap:
$35,252,658,176
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help